Highly Cited Papers | Tudóstér

1.

Lövei, G. L., Ferrante, M.: The Use and Prospects of Nonlethal Methods in Entomology.
Annu. Rev. Entomol. 69 (1), 183-198, 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Ecology, Evolution, Behavior and Systematics

D1 Insect Science

2.

Ágoston, C., Balázs, B., Mónus, F., Varga, A.: Age differences and profiles in pro-environmental behavior and eco-emotions.
Int. J. Behav. Dev. "Accepted by Publisher", 1-13, 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Developmental and Educational Psychology

Q1 Developmental Neuroscience

D1 Education

Q1 Life-span and Life-course Studies

Q1 Social Psychology

D1 Social Sciences (miscellaneous)

3.

Erdélyi, A., Pálfi, E., Tűű, L., Nas, K., Szűcs, Z., Török, M., Jakab, A., Várbíró, S.: The Importance of Nutrition in Menopause and Perimenopause: A Review.
Nutrients. 16 (1), 1-21, (article identifier: 27), 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Food Science

D1 Nutrition and Dietetics

4.

Gaudet, D., Páll, D., Watts, G. F., Nicholls, S. J., Rosenson, R. S., Modesto, K., San Martin, J., Hellawell, J., Ballantyne, C. M.: Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia: the SHASTA-2 Randomized Clinical Trial.
JAMA Cardiol. [Epub ahead of print], 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Cardiology and Cardiovascular Medicine

5.

Fadhel, M. A., Duhaim, A. M., Saihood, A., Sewify, A., Al-Hamadani, M. N. A., Albahri, A. S., Alzubaidi, L., Gupta, A., Mirjalili, S., Gu, Y.: Comprehensive systematic review of information fusion methods in smart cities and urban environments.
Inf Fusion. 107, 1-34, (article identifier: 102317), 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Hardware and Architecture

D1 Information Systems

D1 Signal Processing

D1 Software

6.

Beghini, A., Sammartino, A. M., Papp, Z., Haehling, S. v., Biegus, J., Ponikowski, P., Adamo, M., Falco, L., Lombardi, C. M., Pagnesi, M., Savarese, G., Metra, M., Tomasoni, D.: 2024 update in heart failure.
ESC Heart Failure. 12 (1), 8-42, 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Cardiology and Cardiovascular Medicine

7.

Szekanecz, Z., Buch, M. H., Charles-Schoeman, C., Galloway, J., Karpouzas, G. A., Kristensen, L. E., Ytterberg, S. R., Hamar, A. B., Fleischmann, R.: Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician.
Nat. Rev. Rheumatol. 20 (2), 101-115, 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Rheumatology

8.

Jha, R., Zhang, K., He, Y., Mendlerné Drienyovszki, N., Magyarné Tábori, K., Quinet, M., Germ, M., Kreft, I., Meglic, V., Ikeda, K., Chapman, M. A., Dagmar, J., Podolska, G., Woo, S. H., Bruno, S., Georgiev, M. I., Chrungoo, N., Betekhtin, A., Zhou, M.: Global nutritional challenges and opportunities: Buckwheat, a potential bridge between nutrient deficiency and food security.
Trends Food Sci. Technol. 145, 1-68, (article identifier: 104365), 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Biotechnology

D1 Food Science

9.

Abdul-Rahman, T., Awuah, W. A., Mikhailova, T., Kalmanovich, J., Mehta, A., Cheng Ng, J., Coghlan, M. A., Zivcevska, M., Tedeschi, A. J., de Oliveira, E. C., Kumar, A., Cantu-Herrera, E., Lyndin, M., Sikora, K., Alexiou, A., Bilgrami, A. L., Al-Ghamdi, K. M., Perveen, A., Papadakis, M., Ashraf, G. M.: Antioxidant, anti-inflammatory and epigenetic potential of curcumin in Alzheimer's disease.
Biofactors. 50 (4), 693-708, 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry

Q1 Clinical Biochemistry

Q1 Medicine (miscellaneous)

Q1 Molecular Medicine

10.

Dauw, J., Charaya, K., Lelonek, M., Zegri-Reiriz, I., Nasr, S., Paredes-Paucar, C. P., Borbély, A., Erdal, F., Benkouar, R., Cobo-Marcos, M., Barge-Caballero, G., George, V., Zara, C., Ross, N. T., Barker, D., Lekhakul, A., Frea, S., Ghazi, A. M., Knappe, D., Doghmi, N., Klincheva, M., Fialho, I., Bovolo, V., Findeisen, H., Alhaddad, I. A., Galluzzo, A., Espriella, R. d. l., Tabbalat, R., Miró, Ò., Singh, J. S., Nijst, P., Dupont, M., Martens, P., Mullens, W.: Protocolized Natriuresis-Guided Decongestion Improves Diuretic Response: the Multicenter ENACT-HF Study.
Circ: Heart Failure. 17, 1-10, (article identifier: 011105), 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Cardiology and Cardiovascular Medicine

D1 Medicine (miscellaneous)

11.

Xu, F. W., Wang, K., Liu, T., Tóth, V.: The ALMA Survey of Star Formation and Evolution in Massive Protoclusters with Blue Profiles (ASSEMBLE): Core Growth, Cluster Contraction, and Primordial Mass Segregation.
Astrophys. J. Suppl. Ser. 270 (1), 1-31, (article identifier: 9), 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Astronomy and Astrophysics

D1 Space and Planetary Science

12.

Lorusso, D., Xiang, Y., Hasegawa, K., Scambia, G., Leiva, M., Ramos-Elias, P., Acevedo, A., Sukhin, V., Cloven, N., Santana Gomes, A. J. P. d., Contreras Mejía, F., Reiss, A., Ayhan, A., Lee, J. Y., Saevets, V., Zagouri, F., Gilbert, L., Sehouli, J., Tharavichitkul, E., Lindemann, K., Lazzari, R., Chang, C. L., Lampé, R., Zhu, H., Oaknin, A., Christiaens, M., Polterauer, S., Usami, T., Li, K., Yamada, K., Toker, S., Keefe, S. M., Pignata, S., Duska, L. R., ENGOT-cx11/GOG-3047/KEYNOTE-A18 investigators: Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.
Lancet. 403 (10434), 1341-1350, 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Medicine (miscellaneous)

13.

Pratz, K. W., Jonas, B. A., Pullarkat, V., Thirman, M. J., Garcia, J. S., Döhner, H., Recher, C., Fiedler, W., Yamamoto, K., Wang, J., Yoon, S. S., Wolach, O., Yeh, S. P., Leber, B., Esteve, J., Mayer, J., Porkka, K., Illés, Á., Lemoli, R. M., Turgut, M., Ku, G., Miller, C., Zhou, Y., Zhang, M., Chyla, B., Potluri, J., DiNardo, C. D.: Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia.
Am. J. Hematol. 99 (4), 615-624, 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Hematology

14.

European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration: Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study.
Lancet. S0140-6736 (23), 1-12, 2023.

doi DEA WoS

15.

Hayrapetyan, A., CMS Collaboration: New Structures in the J/[psi]J/psi Mass Spectrum in Proton-Proton Collisions at root{s} = 13 TeV.
Phys. Rev. Lett. 132 (11), 1-20, (article identifier: 111901), 2024.

doi DEA WoS Scopus

16.

Hayrapetyan, A., CMS Collaboration, ATLAS Collaboration: Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at root{s} = 7 and 8 TeV.
Phys. Rev. Lett. 132 (26), 1-37, (article identifier: 261902), 2024.

doi DEA WoS Scopus

17.

Aad, G., ATLAS Collaboration, CMS Collaboration: Evidence for the Higgs Boson Decay to a Z Boson and a Photon at the LHC.
Phys. Rev. Lett. 132, 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Physics and Astronomy (miscellaneous)

18.

GBD 2021 Diseases and Injuries Collaborators: Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
Lancet. 403 (10440), 2133-2161, 2024.

doi DEA WoS Scopus

19.

GBD 2021 Fertility and Forecasting Collaborators: Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
Lancet. 403 (10440), 2057-2099, 2024.

doi DEA WoS Scopus

20.

GBD 2021 Demographics Collaborators: Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
Lancet. 403 (10440), 1989-2056, 2024.

doi DEA WoS Scopus

21.

GBD 2021 Causes of Death Collaborators: Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
Lancet. 403 (10440), 2100-2132, 2024.

doi DEA WoS Scopus